Piperazine

Piperazine

SCHEMBL29044668

C1CNCCN1.CCO.Cl.Cl

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ESR1

The experimentally established mechanism targets of Piperazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.46
TSHR P16473 1/20 0.46
HIF1A Q16665 1/20 0.46
MAPT P10636 1/20 0.46
PDE4A P27815 1/20 0.46
KDR P35968 1/20 0.46
CXCR4 P61073 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
GNAI3 P08754 4/20 0.32
GNAO1 P09471 4/20 0.32
GNAI1 P63096 4/20 0.32
FUCA1 P04066 1/20 0.32
KDM4E B2RXH2 1/20 0.32
GAA P10253 1/20 0.32
CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piperazine SCHEMBL22092466 1.00 ALDH1A1 (0.46) ALDH1A1TSHRHIF1AMAPTPDE4A
Piperazine SCHEMBL1485419 0.96
Piperazine SCHEMBL9506704 0.96 ALDH1A1 (0.50) ALDH1A1TSHRHIF1AMAPTPDE4A
Piperazine SCHEMBL28015400 0.92 ALDH1A1 (0.46) ALDH1A1TSHRHIF1AMAPTPDE4A
Aziridine SCHEMBL64046 0.92
Piperazine SCHEMBL27713827 0.90 ALDH1A1 (0.38) ALDH1A1TSHRHIF1AMAPTPDE4A
Cyclohexane SCHEMBL28639868 0.89 ALDH1A1 (0.44) ALDH1A1TSHRHIF1AMAPTPDE4A
Cyclohexane SCHEMBL29042400 0.86 ALDH1A1 (0.41) ALDH1A1TSHRHIF1AMAPTPDE4A
Alcohol SCHEMBL27962627 0.86 CXCR4 (0.60) ALDH1A1TSHRHIF1AMAPTPDE4A
Aziridine SCHEMBL27979623 0.85

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116120243-A aPKC inhibitor compound intermediate fragment, preparation method and application thereof 都创(上海)医药科技股份有限公司 2023-05-16 CN disclosed